Abstract
Amyloid beta peptide (Aβ) is implicated in the pathogenesis of Alzheimers disease (AD), particularly as oligomers or polymers that are correlated with Ab cellular toxicity. Inhibition of the formation of toxic forms of Aβ has therefore emerged as one approach to the treatment of AD. This article reviews efforts to adapt the structure of Aβ to the design and testing of peptide-based inhibitors of Aβ polymerization of interest as potential AD therapeutics.
Keywords: Peptide Inhibitors, Beta Amyloid Aggregation, Amyloid beta peptide
Current Topics in Medicinal Chemistry
Title: Peptide Inhibitors of Beta Amyloid Aggregation
Volume: 2 Issue: 4
Author(s): Mark A. Findeis
Affiliation:
Keywords: Peptide Inhibitors, Beta Amyloid Aggregation, Amyloid beta peptide
Abstract: Amyloid beta peptide (Aβ) is implicated in the pathogenesis of Alzheimers disease (AD), particularly as oligomers or polymers that are correlated with Ab cellular toxicity. Inhibition of the formation of toxic forms of Aβ has therefore emerged as one approach to the treatment of AD. This article reviews efforts to adapt the structure of Aβ to the design and testing of peptide-based inhibitors of Aβ polymerization of interest as potential AD therapeutics.
Export Options
About this article
Cite this article as:
Findeis A. Mark, Peptide Inhibitors of Beta Amyloid Aggregation, Current Topics in Medicinal Chemistry 2002; 2 (4) . https://dx.doi.org/10.2174/1568026024607508
DOI https://dx.doi.org/10.2174/1568026024607508 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Targets to Promote Central Nervous System Regeneration
Current Neurovascular Research Nanomaterials for Improving the Properties of Polymeric Electrolyte Membranes in Energy Managing Devices
Nanoscience & Nanotechnology-Asia Antihistamines: Past Answers and Present Questions
Current Drug Safety Synthesis and Biological Evaluation of Quinazoline Derivatives as Potential Anticancer Agents (II)
Anti-Cancer Agents in Medicinal Chemistry Updated Electrocardiographic Classification of Acute Coronary Syndromes
Current Cardiology Reviews Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists
Current Neuropharmacology Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Current Pharmaceutical Design Effects of Chronic Lamotrigine Administration on Maximal Electroshock- Induced Seizures in Mice
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic:Nicotinamide Adenine Dinucleotide Biology and Disease(Executive Editor: W. Todd Penberthy)]
Current Pharmaceutical Design Role of Metalloproteinases in Tendon Pathophysiology
Mini-Reviews in Medicinal Chemistry Michael Acceptors as Cysteine Protease Inhibitors
Mini-Reviews in Medicinal Chemistry Role of Metallothionein in Inflammatory Lung Diseases
Current Respiratory Medicine Reviews Use of Topiceuticals (Topically Applied, Peripherally Acting Drugs) in the Treatment of Chronic Pain
Current Drug Therapy Phosphodiesterase-5 Inhibitors: Future Perspectives
Current Pharmaceutical Design Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Estrogen Receptors alpha and beeta Two Receptors of a Kind
Current Medicinal Chemistry New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews Molecular Characterization of the T Cell Repertoire Using Immuno-scope Analysis and its Possible Implementation in Clinical Practice
Current Molecular Medicine Dissecting the Mechanisms of Thrombogenesis and Atherosclerosis for Neurodegenerative Disorders
Current Neurovascular Research Economics of Pharmacogenomics: Rethinking Beyond QALYs?
Current Pharmacogenomics and Personalized Medicine